Kalohexis

Geneva, Switzerland, August,11, 2026 Spineart has announced that its BAGUERA® C cervical disc has received U.S. Food and Drug...

Northbrook, Illinois, August,11, 2026 Kalohexis, Inc., a clinical-stage biotechnology company developing therapies that target the melanocortin system, has appointed...